Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥55.69 Million ≈ $8.15 Million USD) by net assets (CN¥1.33 Billion ≈ $194.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Cheng Yi Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Zhejiang Cheng Yi Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Zhejiang Cheng Yi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Cheng Yi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Cheng Yi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Beijing Hanbang Technology Corp SHE:300449	-0.118x
BOKU INC. REG S DL-0001 F:B04	N/A
Nepes Corporation KQ:033640	0.041x
Hexagon Purus As OL:HPUR	-1.040x
CoinShares International Ltd ST:CS	-0.162x
Hubei Yingtong Telecommunication Cable Co Ltd SHE:002861	0.024x
Posiflex Technology Inc TW:8114	-0.061x
Zhewen Pictures Group Co Ltd SHG:601599	0.048x

Annual Cash Flow Conversion Efficiency for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Cheng Yi Pharmaceutical Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.27 Billion ≈ $185.12 Million	CN¥205.72 Million ≈ $30.10 Million	0.163x	-0.10%
2023-12-31	CN¥1.20 Billion ≈ $175.10 Million	CN¥194.78 Million ≈ $28.50 Million	0.163x	+7.02%
2022-12-31	CN¥1.09 Billion ≈ $159.64 Million	CN¥165.94 Million ≈ $24.28 Million	0.152x	+5.89%
2021-12-31	CN¥998.88 Million ≈ $146.17 Million	CN¥143.49 Million ≈ $21.00 Million	0.144x	-28.41%
2020-12-31	CN¥886.09 Million ≈ $129.66 Million	CN¥177.81 Million ≈ $26.02 Million	0.201x	-14.76%
2019-12-31	CN¥768.96 Million ≈ $112.52 Million	CN¥181.01 Million ≈ $26.49 Million	0.235x	+18.06%
2018-12-31	CN¥673.54 Million ≈ $98.56 Million	CN¥134.30 Million ≈ $19.65 Million	0.199x	+79.10%
2017-12-31	CN¥599.57 Million ≈ $87.74 Million	CN¥66.75 Million ≈ $9.77 Million	0.111x	-67.19%
2016-12-31	CN¥280.17 Million ≈ $41.00 Million	CN¥95.08 Million ≈ $13.91 Million	0.339x	+7.65%
2015-12-31	CN¥259.92 Million ≈ $38.03 Million	CN¥81.94 Million ≈ $11.99 Million	0.315x	-7.44%
2014-12-31	CN¥246.95 Million ≈ $36.14 Million	CN¥84.11 Million ≈ $12.31 Million	0.341x	+42.35%
2013-12-31	CN¥201.40 Million ≈ $29.47 Million	CN¥48.19 Million ≈ $7.05 Million	0.239x	+12.28%
2012-12-31	CN¥178.13 Million ≈ $26.07 Million	CN¥37.96 Million ≈ $5.55 Million	0.213x	+117.73%
2011-12-31	CN¥102.60 Million ≈ $15.01 Million	CN¥10.04 Million ≈ $1.47 Million	0.098x	--

About Zhejiang Cheng Yi Pharmaceutical Co Ltd

SHG:603811 China Drug Manufacturers - Specialty & Generic

Market Cap

$510.08 Million

CN¥3.49 Billion CNY

Market Cap Rank

#12274 Global

#3589 in China

Share Price

CN¥10.65

Change (1 day)

-0.09%

52-Week Range

CN¥8.94 - CN¥16.82

All Time High

CN¥19.93